Concepedia

İbrahim Günay

İG

Statistics

Publications

13

Citations

707

H-Index

13

Active since

1995

Affiliations

Novartis (United States)(Current)

Neurobehavioral Systems

Novartis (Switzerland)

Central Institute of Mental Health

Charité - Universitätsmedizin Berlin

İbrahim Günay is an author at Novartis (United States) specializing in medicine, psychopharmacology, and pharmacotherapy.

Publications per year

1995–2009

13

Publications

13

A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients With Dementia

David L. Sultzer, Kevin F. Gray, İbrahim Günay et al. · American Journal of Geriatric Psychiatry · 1997 · 133 citations

Medicine, Pharmacology, Pharmacotherapy +12

Effects of rivastigmine on cognitive function in patients with traumatic brain injury

Jonathan Silver, Barbara Koumaras, M. Chen et al. · Neurology · 2006 · 124 citations

Medicine, Neurology, Neuroscience +17

A Double-Blind Comparison of Trazodone and Haloperidol for Treatment of Agitation in Patients With Dementia

David L. Sultzer, Kevin F. Gray, İbrahim Günay et al. · American Journal of Geriatric Psychiatry · 1997 · 121 citations

Medicine, Pharmacology, Pharmacotherapy +12

Long-term effects of rivastigmine capsules in patients with traumatic brain injury

Jonathan Silver, Barbara Koumaras, Xiangyi Meng et al. · Brain Injury · 2009 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +13

Does Behavioral Improvement with Haloperidol or Trazodone Treatment Depend on Psychosis or Mood Symptoms in Patients with Dementia?

David L. Sultzer, Kevin F. Gray, İbrahim Günay et al. · Journal of the American Geriatrics Society · 2001 · 54 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

1–5 of 13